Table I.
Compound | JA Treatment | BTH Treatment |
---|---|---|
2-Ethyl hexanole | 0.59 ± 0.52 | 3.22 ± 1.48* |
cis-β-Ocimene | 8.10 ± 1.67 | 0.62 ± 0.44 |
Decanal | 0.67 ± 0.55 | 0.93 ± 0.65 |
Linalool | 6.87 ± 1.47 | 1.35 ± 0.90 |
Nonanal | 0.00 ± 0.00 | 0.77 ± 0.50* |
cis-Hexenyl butyrate | 1.42 ± 0.66 | 0.55 ± 0.51 |
MeSA | 0.45 ± 0.37 | 1.26 ± 1.00* |
cis-Hexenyl isovalerate | 18.11 ± 3.17 | 1.05 ± 0.49 |
Indole | 22.35 ± 2.73 | 4.32 ± 1.04 |
cis-Hexenyl acetate | 0.66 ± 0.33 | 0.00 ± 0.00 |
cis-Jasmone | 18.20 ± 2.89 | 0.00 ± 0.00 |
β-Caryophyllene | 3.32 ± 1.12 | 1.36 ± 0.82 |
trans-Geranyl acetate | 0.29 ± 0.52 | 0.00 ± 0.00 |
Methyl jasmonate | 13.56 ± 2.11 | 1.77 ± 0.61 |